Characterization in Rats of the Anxiolytic Potential of ELB139 [1-(4-Chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a New Agonist at the Benzodiazepine Binding Site of the GABAA Receptor-Reference-Cited by-同舟云学术

Characterization in Rats of the Anxiolytic Potential of ELB139 [1-(4-Chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a New Agonist at the Benzodiazepine Binding Site of the GABAA Receptor

Published:2005-04-28 Issue:2 Volume:314 Page:717-724
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Langen Barbara,Egerland Ute,Bernöster Katrin,Dost Rita,Unverferth Klaus,Rundfeldt Chris

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference35 articles.

1. Anxioselective Compounds Acting at the GABAA Receptor Benzodiazepine Binding Site

2. Imidazenil prevention of alprazolam-induced acquisition deficit in patas monkeys is devoid of tolerance

3. Blanchard DC, Blanchard RJ, and Rodgers RJ (1991) Risk assessment and models of anxiety, in Animal Models in Psychopharmacology (Advances in Pharmacology Science) (Oliver B, Mos J, and Slangen JL eds) pp 117-134, BirkhÃ¤user, Basel, Switzerland.

4. Amitriptylinoxide: Receptor-binding Profile Compared with other Antidepressant Drugs

5. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early deprivation increases high-leaning behavior, a novel anxiety-like behavior, in the open field test in rats;Neuroscience Research;2017-10

2. Tests for Anxiolytic Activity;Drug Discovery and Evaluation: Pharmacological Assays;2017

3. To what extent is it possible to dissociate the anxiolytic and sedative/hypnotic properties of GABAA receptors modulators?;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2016-11

4. Concordance and incongruence in preclinical anxiety models: Systematic review and meta-analyses;Neuroscience & Biobehavioral Reviews;2016-09

5. Tests for Anxiolytic Activity;Drug Discovery and Evaluation: Pharmacological Assays;2016